Fibronectin is a dimeric glycoprotein crucial for cell adhesion and tissue repair.
Alternative splicing of fibronectin pre-mRNA generates variants with different functional properties.
The IIICS and ED regions are key sites of alternative splicing, influencing fibronectin's structure and function.
Purpose of the Study:
To quantitatively analyze the expression of the IIICS sequence in human fibronectin from various sources.
To investigate the sialylation status of the heparin-binding domain 5 in fibronectin from different cell types and plasma.
Main Methods:
Utilized two monoclonal antibodies targeting distinct epitopes on fibronectin domain 5.
Performed quantitative analysis of fibronectin subunit expression and sialylation.
Compared fibronectin from tumor-derived cells, SV40-transformed cells, normal fibroblasts, embryonic fibroblasts, and human plasma.
Main Results:
Fibronectin subunits with the IIICS sequence were more prevalent in tumor-derived or transformed cells compared to normal fibroblasts or plasma.
Sialylation of the heparin-binding domain 5 was significantly higher in fibronectin from transformed cells and embryonic fibroblasts (45-65%) than in normal adult fibroblasts (24-28%).
No sialylation was detected on domain 5 of fibronectin from human plasma.
Conclusions:
Alternative splicing and post-translational modifications like sialylation are differentially regulated in fibronectin from normal versus transformed cells.
These molecular differences in fibronectin may contribute to altered cell behavior and tissue microenvironments in disease states.
Fibronectin from human plasma exhibits distinct molecular characteristics compared to that from cellular sources.